{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Inovio Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"INO"},"Address":{"label":"Address","value":"660 WEST GERMANTOWN PIKE,SUITE 110, PLYMOUTH MEETING, Pennsylvania, 19462, United States"},"Phone":{"label":"Phone","value":"+1 267 440-4200"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies."},"CompanyUrl":{"label":"Company Url","value":"https://www.inovio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jacqueline E. Shea","title":"President, Chief Executive Officer & Director"},{"name":"Jeffrey Skolnik","title":"Senior Vice President-Clinical Development"},{"name":"Laurent M. Humeau","title":"Chief Scientific Officer"},{"name":"Michael Sumner","title":"Chief Medical Officer"},{"name":"Stephen Kemmerrer","title":"Senior Vice President-Engineering Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}